Asthma Clinical Trial
Official title:
Implementation of ACT Through Facebook for Teenagers With Asthma
The investigators hypothesize that at the end of the 12-month trial, teenagers regularly self-monitoring their asthma control with ACT administered through Facebook will have improved ACT scores as compared with teenagers receiving usual care.
The investigators propose to administer the Asthma Control Test (ACT), a clinically validated
and reliable measure of asthma control, to a pediatric pulmonary patient population, using
novel channels to improve usage of the tool and health outcomes. The investigators will
administer ACT to patients using Facebook to monitor asthma control and notify clinicians
when there is deterioration of control.
The goal is to improve health outcomes in patients with asthma by measuring adherence to the
use of monitoring tool, follow-up visits to their specialist, and hospitalization/Emergency
Department (ED) visits. To achieve this, the investigators will use a novel technology
platform that is simple, secure, private and easily scalable to other relevant sites and
groups, without the need for additional investment. Currently, patients take the ACT survey
only during their scheduled office appointments. The aim of the study is to increase the use
of ACT to monitor patients who see a pediatric pulmonologist to promote regular
self-monitoring.
ACT is a short symptom-based survey consisting of 5 questions, validated in English and
Spanish. Participants will receive reminders on Facebook every month to login to the study
website to complete the ACT survey therefore allowing patients to easily take the survey on a
regular basis, and receive reminders and educational content in the media spaces they already
inhabit. Participants would receive reminders and links in the same way they would receive
other reminders or notifications from Facebook. The system will rate asthma control and send
patients and their specialist notification of status if it reaches critical levels, defined
as a score of 14 or lower on the ACT survey. This will be a system generated notification,
based on a protocol developed in conjunction with the physicians at the Massachusetts General
Hospital (MGH) pediatric pulmonary department.
The intervention will study the efficacy of electronic social networks in engaging teenagers
in their asthma control over time, using a simple but effective symptom-based survey tool.
Both patients and providers would receive notifications in case of deteriorating control,
which could result in early intervention and lead to better clinical outcomes by prompting
timely intervention by the clinician. The Center for Connected Health (CCH) will work with
the MGH Department of Pulmonology, as well as the Pediatric Asthma group at Partners
Community HealthCare Inc. (PCHI) to enroll ambulatory teenagers with asthma in the research
study for one year.
120 participants will be enrolled and randomly assigned to one of two groups.
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT04624425 -
Additional Effects of Segmental Breathing In Asthma
|
N/A | |
| Terminated |
NCT04410523 -
Study of Efficacy and Safety of CSJ117 in Patients With Severe Uncontrolled Asthma
|
Phase 2 | |
| Active, not recruiting |
NCT03927820 -
A Pharmacist-Led Intervention to Increase Inhaler Access and Reduce Hospital Readmissions (PILLAR)
|
N/A | |
| Completed |
NCT04617015 -
Defining and Treating Depression-related Asthma
|
Early Phase 1 | |
| Recruiting |
NCT03694158 -
Investigating Dupilumab's Effect in Asthma by Genotype
|
Phase 4 | |
| Terminated |
NCT04946318 -
Study of Safety of CSJ117 in Participants With Moderate to Severe Uncontrolled Asthma
|
Phase 2 | |
| Completed |
NCT04450108 -
Vivatmo Pro™ for Fractional Exhaled Nitric Oxide (FeNO) Monitoring in U.S. Asthmatic Patients
|
N/A | |
| Completed |
NCT03086460 -
A Dose Ranging Study With CHF 1531 in Subjects With Asthma (FLASH)
|
Phase 2 | |
| Completed |
NCT01160224 -
Oral GW766944 (Oral CCR3 Antagonist)
|
Phase 2 | |
| Completed |
NCT03186209 -
Efficacy and Safety Study of Benralizumab in Patients With Uncontrolled Asthma on Medium to High Dose Inhaled Corticosteroid Plus LABA (MIRACLE)
|
Phase 3 | |
| Completed |
NCT02502734 -
Effect of Inhaled Fluticasone Furoate on Short-term Growth in Paediatric Subjects With Asthma
|
Phase 3 | |
| Completed |
NCT01715844 -
L-Citrulline Supplementation Pilot Study for Overweight Late Onset Asthmatics
|
Phase 1 | |
| Terminated |
NCT04993443 -
First-In-Human Study to Evaluate the Safety, Tolerability, Immunogenicity, and Pharmacokinetics of LQ036
|
Phase 1 | |
| Completed |
NCT02787863 -
Clinical and Immunological Efficiency of Bacterial Vaccines at Adult Patients With Bronchopulmonary Pathology
|
Phase 4 | |
| Recruiting |
NCT06033833 -
Long-term Safety and Efficacy Evaluation of Subcutaneous Amlitelimab in Adult Participants With Moderate-to-severe Asthma Who Completed Treatment Period of Previous Amlitelimab Asthma Clinical Study
|
Phase 2 | |
| Completed |
NCT03257995 -
Pharmacodynamics, Safety, Tolerability, and Pharmacokinetics of Two Orally Inhaled Indacaterol Salts in Adult Subjects With Asthma.
|
Phase 2 | |
| Completed |
NCT02212483 -
Clinical Effectiveness and Economical Impact of Medical Indoor Environment Counselors Visiting Homes of Asthma Patients
|
N/A | |
| Recruiting |
NCT04872309 -
MUlti-nuclear MR Imaging Investigation of Respiratory Disease-associated CHanges in Lung Physiology
|
||
| Withdrawn |
NCT01468805 -
Childhood Asthma Reduction Study
|
N/A | |
| Recruiting |
NCT05145894 -
Differentiation of Asthma/COPD Exacerbation and Stable State Using Automated Lung Sound Analysis With LungPass Device
|